In LN, where a baseline sample was not available, the levels of CD8+ T cells post MT807R1 administration were 99.6% and 95.3% in the pre-infection and pre-ART CD8+ depletion groups, respectively, as compared with undepleted animals (Extended Data Fig. 2c). This evidence concerns the gene CD8A and infection.